As of 28 Aug 2026, Transgene Biotek Ltd share price is ₹2.88. The stock opened at ₹2.88 and had closed at ₹2.82 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1.83 and a high of ₹4.50. In terms of performance, Transgene Biotek Ltd share price has increased by 8.27% over the past six months and has decreased by 25.77% over the last year.
Transgene Biotek Charts
Transgene Biotek Ltd Overview
About Transgene Biotek
Transgene Biotek is an Indian public biotech firm, established in 1990, focused on R&D for vaccines, oncology, biogenerics, and novel drug delivery (oral/nasal proteins/peptides) for unmet needs, exporting to various global markets and developing treatments for cancer, auto-immune issues, etc
Transgene Biotek Ltd Historical Performance
Transgene Biotek Ltd Fundamental Analysis
Transgene Biotek Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 0.06 | 0.20 | 0.05 | 0.05 | 0.05 |
| EBITDA | -0.06 | -0.13 | -0.05 | -0.08 | -0.13 |
| Net Profit | -0.39 | -0.46 | -0.37 | -0.39 | -0.43 |
| EPS | -0.05 | -0.06 | -0.05 | -0.05 | -0.06 |
Transgene Biotek Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 45.26 |
| MACD | -0.05 |
| 20-Day SMA | 2.90 |
Transgene Biotek Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Transgene Biotek Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,800.00+0.38% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,009.00+0.40% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹915.65+0.20% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Transgene Biotek Ltd today is ₹2.88 on NSE and ₹2.88 on BSE.
- The 52-week high of Transgene Biotek Ltd is ₹4.50, while the 52-week low is ₹1.83.
- The current market capitalisation of Transgene Biotek Ltd is approximately ₹21 crore.
- The P/E (Price-to-Earnings) ratio of Transgene Biotek Ltd is -9.60. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Transgene Biotek Ltd is 1.97. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Transgene Biotek Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Transgene Biotek Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Transgene Biotek Ltd has delivered a return of approximately -34.99%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Transgene Biotek Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 23.64% promoters, 0.00% FIIs, 0.00% DIIs, and 71.70% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
